Immediate Impact
3 from Science/Nature 65 standout
Citing Papers
Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma
2023 Standout
Metal-based anticancer agents as immunogenic cell death inducers: the past, present, and future
2022 Standout
Works of E. Vokes being referenced
Phase II study of bortezomib in advanced or metastatic urothelial cancer. A trial of the Princess Margaret Hospital [PMH] Phase II Consortium
2005
272 A phase I study of JM-216 with concomitant radiation therapy for patients (pts) with malignancies of the chest
1997
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| E. Vokes | 89 | 164 | 30 | 197 | 169 | 20 | 491 | |
| C. Papadimitriou | 134 | 279 | 61 | 80 | 95 | 28 | 566 | |
| S. Molica | 53 | 192 | 18 | 182 | 80 | 25 | 534 | |
| P.Y. Dietrich | 146 | 175 | 18 | 94 | 114 | 16 | 431 | |
| Séverine Valmary | 79 | 195 | 17 | 76 | 67 | 15 | 497 | |
| Jan Willems | 160 | 192 | 46 | 32 | 183 | 16 | 543 | |
| Carlo Alberto Giorgi | 109 | 273 | 53 | 84 | 72 | 35 | 487 | |
| Justus Duyster | 51 | 144 | 100 | 69 | 140 | 11 | 482 | |
| Ling Chen | 49 | 322 | 58 | 208 | 41 | 16 | 538 | |
| Qi-rong Geng | 125 | 271 | 12 | 65 | 152 | 15 | 517 | |
| Damian DiCostanzo | 50 | 128 | 12 | 33 | 59 | 19 | 531 |
All Works
Loading papers...